These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 767114)

  • 1. Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma.
    Könyves I; Nordenskjöld B; Forshell GP; de Schryver A; Westerberg-Larsson H
    Eur J Cancer (1965); 1975 Dec; 11(12):841-4. PubMed ID: 767114
    [No Abstract]   [Full Text] [Related]  

  • 2. Lomustine treatment of metastatic renal cell carcinoma.
    Mittelman A; Albert DJ; Murphy GP
    JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
    [No Abstract]   [Full Text] [Related]  

  • 3. Advanced breast cancer: are the traditional stratification parameters still of value when patients are treated with combination chemotherapy?
    Valagussa P; Brambilla C; Bonadonna G
    Eur J Cancer (1965); 1979 Apr; 15(4):565-71. PubMed ID: 374086
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 5. Simultaneous hormone- and chemotherapy, compared with hormone therapy followed by chemotherapy in the treatment of metastasising mammary carcinoma--preliminary results of a current study.
    Cavalli F; Alberto P; Jungi WF; Martz G; Barrelet L; Obrecht JP; Brunner KW
    Recent Results Cancer Res; 1980; 71():151-4. PubMed ID: 6988912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of adjuvant chemotherapy.
    Rubens RD
    Surg Clin North Am; 1978 Aug; 58(4):789-93. PubMed ID: 356299
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trial of the cyclic imide 1-(morpholinomethyl)-4-phtalimido-piperidindione-2,6 (CG 603) in advanced breast cancer.
    Eur J Cancer (1965); 1972 Apr; 8(2):157-8. PubMed ID: 4561334
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy in disseminated carcinoma of the breast.
    Stutz FH; Blom J; Tormey DC
    Oncology; 1974; 29(2):139-46. PubMed ID: 4525917
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271).
    Cunningham TJ; Nemoto T; Rosner D; Knight E; Taylor S; Rosenbaum C; Horton J; Dao T
    Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).
    Gottlieb JA; Guarino AM; Call JB; Oliverio VT; Block JB
    Cancer Chemother Rep; 1970 Dec; 54(6):461-70. PubMed ID: 4946015
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung.
    Weiss AJ; Wilson WL
    Cancer Chemother Rep; 1971 Jun; 55(3):299-302. PubMed ID: 5115850
    [No Abstract]   [Full Text] [Related]  

  • 12. Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).
    Rossof AH; Slayton RE; Perlia CP
    Cancer; 1972 Dec; 30(6):1451-6. PubMed ID: 4641756
    [No Abstract]   [Full Text] [Related]  

  • 13. A dose-response evaluation of androgens in the treatment of metastatic breast cancer.
    Talley RW; Haines CR; Waters MN; Goldenberg IS; Olson KB; Bisel HF
    Cancer; 1973 Aug; 32(2):315-20. PubMed ID: 4579091
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
    Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
    Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
    Rossi A; Bonadonna G; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1977; (62):134-42. PubMed ID: 341246
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemo immunotherapy of advanced breast cancer with BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Buzdar A; Burgess MA; Richman SP; Tashima CK; Schwarz M; Hersh EM
    Recent Results Cancer Res; 1977; (62):143-50. PubMed ID: 601328
    [No Abstract]   [Full Text] [Related]  

  • 17. AMSA and peptichemio in the treatment of advances metastatic breast cancer: a phase II study.
    Buzdar AU; Legha SS; Hortobagyi GN; Powell KC; Blumenschein GR; Bodey GP
    Am J Clin Oncol; 1982 Aug; 5(4):383-7. PubMed ID: 6896794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II evaluation of piperazinedione in metastatic breast carcinoma.
    Palmer RL; Samal BA; Vaughn CB; Tranum BL
    Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 20. Hexamethylmelamine (NSC-13875) for acute leukemia and solid tumors in children.
    Dyment PG; Fernbach DJ; Sutow WW
    J Clin Pharmacol New Drugs; 1973; 13(2):111-3. PubMed ID: 4568295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.